机构:[1]Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]Department of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[3]Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[4]Division of Nephrology, National Clinical Research Center for Geriatrics, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.四川大学华西医院
The author(s) declare financial support was received for the
research, authorship, and/or publication of this article. This research
was supported by 1•3•5 project for disciplines of excellence-Clinical
Research Incubation Project,West China Hospital, Sichuan University
(NO.2019HXFH067) and the Sciencetechnology Support Plan
Projects in Sichuan Province (No2021YFS0162).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|3 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
通讯作者:
推荐引用方式(GB/T 7714):
Wang Rongzhong,Wang Shiyan,Jiang Hua,et al.Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma[J].Frontiers In Oncology.2024,14:1430684.doi:10.3389/fonc.2024.1430684.
APA:
Wang Rongzhong,Wang Shiyan,Jiang Hua,Lan Yingmei&Yu Shaobin.(2024).Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma.Frontiers In Oncology,14,
MLA:
Wang Rongzhong,et al."Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma".Frontiers In Oncology 14.(2024):1430684